Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105085634A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105085634A reveals a safer Oxyma-based solid-phase synthesis for Degarelix, offering high purity and significant cost reduction in API manufacturing for global supply chains.